Resistance Pattern of Ciprofloxacin Against Different Pathogens
Objectives: Ciprofloxacin is a broad-spectrum antibiotic widely prescribed in clinical and hospital settings. The emergence of antimicrobial resistance against effective antibiotics is a global issue. The objective of study is the surveillance of ciprofloxacin against common pathogens.Methods: To in...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Oman Medical Specialty Board
2010-10-01
|
Series: | Oman Medical Journal |
Subjects: | |
Online Access: | http://www.omjournal.org/fultext_PDF.aspx?DetailsID=24&type=fultext |
id |
doaj-6b4a971954da4d68bc18ba861ad187c1 |
---|---|
record_format |
Article |
spelling |
doaj-6b4a971954da4d68bc18ba861ad187c12020-11-24T21:20:14ZengOman Medical Specialty BoardOman Medical Journal1999-768X2070-52042010-10-01254294298Resistance Pattern of Ciprofloxacin Against Different PathogensSyeda Q. AliAle ZehraBaquar S. NaqviShahjahan ShahRabia BushraObjectives: Ciprofloxacin is a broad-spectrum antibiotic widely prescribed in clinical and hospital settings. The emergence of antimicrobial resistance against effective antibiotics is a global issue. The objective of study is the surveillance of ciprofloxacin against common pathogens.Methods: To investigate the present status of antimicrobial resistance against ciprofloxacin, five hundred and twenty four clinical isolates of Escherichia coli (30%), Staphylococcus aureus (33%), Salmonella typhi (9%), Klebsiella pneumonia (14%) and Pseudomonas aeruginosa (14%) were collected during study from January, 2008 to February, 2009 from different pathological laboratories running in and out side hospitals located in Karachi, Pakistan. These pathogens were isolated from specimens of both in and out patients. The in-vitro antimicrobial activity of ciprofloxacin was carried out by Disc Diffusion Method (Kirby-Bauer test).Results: Showed that ciprofloxacin is 27.02%, 21.95%, 16.66%, 72.22% and 44.44% resistant to Escherichia coli, Staphylococcus aureus, Salmonella typhi, Klebsiella pneumonia and Pseudomonas aeruginosa respectively.Conclusion: It is concluded that these clinical isolates have started developing resistance against ciprofloxacin due to its irrational and inappropriate use. Continuous surveillance is crucial to monitor the antimicrobial resistance among pathogens.http://www.omjournal.org/fultext_PDF.aspx?DetailsID=24&type=fultextpathogensciproflaxin |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Syeda Q. Ali Ale Zehra Baquar S. Naqvi Shahjahan Shah Rabia Bushra |
spellingShingle |
Syeda Q. Ali Ale Zehra Baquar S. Naqvi Shahjahan Shah Rabia Bushra Resistance Pattern of Ciprofloxacin Against Different Pathogens Oman Medical Journal pathogens ciproflaxin |
author_facet |
Syeda Q. Ali Ale Zehra Baquar S. Naqvi Shahjahan Shah Rabia Bushra |
author_sort |
Syeda Q. Ali |
title |
Resistance Pattern of Ciprofloxacin Against Different Pathogens |
title_short |
Resistance Pattern of Ciprofloxacin Against Different Pathogens |
title_full |
Resistance Pattern of Ciprofloxacin Against Different Pathogens |
title_fullStr |
Resistance Pattern of Ciprofloxacin Against Different Pathogens |
title_full_unstemmed |
Resistance Pattern of Ciprofloxacin Against Different Pathogens |
title_sort |
resistance pattern of ciprofloxacin against different pathogens |
publisher |
Oman Medical Specialty Board |
series |
Oman Medical Journal |
issn |
1999-768X 2070-5204 |
publishDate |
2010-10-01 |
description |
Objectives: Ciprofloxacin is a broad-spectrum antibiotic widely prescribed in clinical and hospital settings. The emergence of antimicrobial resistance against effective antibiotics is a global issue. The objective of study is the surveillance of ciprofloxacin against common pathogens.Methods: To investigate the present status of antimicrobial resistance against ciprofloxacin, five hundred and twenty four clinical isolates of Escherichia coli (30%), Staphylococcus aureus (33%), Salmonella typhi (9%), Klebsiella pneumonia (14%) and Pseudomonas aeruginosa (14%) were collected during study from January, 2008 to February, 2009 from different pathological laboratories running in and out side hospitals located in Karachi, Pakistan. These pathogens were isolated from specimens of both in and out patients. The in-vitro antimicrobial activity of ciprofloxacin was carried out by Disc Diffusion Method (Kirby-Bauer test).Results: Showed that ciprofloxacin is 27.02%, 21.95%, 16.66%, 72.22% and 44.44% resistant to Escherichia coli, Staphylococcus aureus, Salmonella typhi, Klebsiella pneumonia and Pseudomonas aeruginosa respectively.Conclusion: It is concluded that these clinical isolates have started developing resistance against ciprofloxacin due to its irrational and inappropriate use. Continuous surveillance is crucial to monitor the antimicrobial resistance among pathogens. |
topic |
pathogens ciproflaxin |
url |
http://www.omjournal.org/fultext_PDF.aspx?DetailsID=24&type=fultext |
work_keys_str_mv |
AT syedaqali resistancepatternofciprofloxacinagainstdifferentpathogens AT alezehra resistancepatternofciprofloxacinagainstdifferentpathogens AT baquarsnaqvi resistancepatternofciprofloxacinagainstdifferentpathogens AT shahjahanshah resistancepatternofciprofloxacinagainstdifferentpathogens AT rabiabushra resistancepatternofciprofloxacinagainstdifferentpathogens |
_version_ |
1726003288388665344 |